Needham, MA, January 19, 2025 – MLAB Biosciences (MLAB) is excited to share that our abstract “MLAB-001: a novel muscle-targeted Notch agonist as a potential new treatment for Duchenne muscular dystrophy” has been selected for Oral and Poster Presentations at the MDA Conference 2025 on Wednesday, March 19, 2025.

MLAB-001 aims to enhance muscle regeneration, an aspect that currently approved therapies for DMD are not equipped to address and may present a new therapeutic strategy for treating DMD and other genetic muscular dystrophies.